Search

Your search keyword '"Pulmonary embolism -- Drug therapy -- Research"' showing total 8 results
Start Over Descriptor "Pulmonary embolism -- Drug therapy -- Research"
8 results on '"Pulmonary embolism -- Drug therapy -- Research"'

1. Studies Conducted at Sao Paulo State University (UNESP) on Pulmonary Embolism Recently Reported (Anticoagulant treatment for subsegmental pulmonary embolism)

Subjects
Drug therapy, Research, Mortality -- Brazil, Pulmonary embolism -- Drug therapy -- Research, Physical fitness, Coronary heart disease -- Drug therapy -- Research, Medical research, Anticoagulants -- Research, Death, Lung diseases, Accounting, Respiratory tract diseases, Diseases, Obesity, Embolism, Cardiovascular diseases, Stroke, Editors
Abstract

2020 FEB 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Lung Diseases and Conditions - Pulmonary Embolism have [...]

Published
2020

2. Reports from Department of Pharmacy Highlight Recent Findings in Pulmonary Embolism (Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced ...)

Subjects
Drug therapy, Research, Pulmonary embolism -- Drug therapy -- Research, Physical fitness, Tissue plasminogen activator -- Research, Pharmacy, Respiratory system agents -- Research, Medical research, Anticoagulants -- Research
Abstract

2017 SEP 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Lung Diseases and Conditions - Pulmonary Embolism. [...]

Published
2017

3. Bleeding time and other laboratory tests to monitor the safety and efficacy of thrombolytic therapy

Author

Hirsch, Denise R. and Goldhaber, Samuel Z.

Subjects
Blood -- Medical examination, Pulmonary embolism -- Drug therapy -- Research, Thrombolytic drugs -- Usage -- Health aspects, Health, Drug therapy, Usage, Research, Health aspects
Abstract

Widespread use of thrombolytic agents in a variety of settings has highlighted the need for measures of safety and efficacy. Previously used laboratory parameters, such as decreasing levels of fibrinogen [...]

Published
1990

4. Study Data from School of Medicine Update Knowledge of Pulmonary Embolism

Subjects
Embolism -- Drug therapy -- Research, Pulmonary embolism -- Drug therapy -- Research, Health, Women's issues/gender studies
Abstract

New research, 'Pulmonary embolism evaluation in the pregnant patient: a review of current imaging approaches,' is the subject of a report. 'Pregnancy is characterized by a higher incidence of pulmonary [...]

Published
2012

5. Pneumococcal vaccines; use of rivaroxaban for DVT and PE

Author

DeDea, Larissa

Subjects
Drug therapy, Research, Dosage and administration, Health aspects, Pulmonary embolism -- Drug therapy -- Research, Pneumococcal vaccines -- Health aspects -- Research, Rivaroxaban -- Dosage and administration -- Research, Venous thrombosis -- Drug therapy -- Research, Pneumococcal vaccine -- Health aspects -- Research
Abstract

* WHAT ARE THE DIFFERENT TYPES OF PNEUMOCOCCAL VACCINES? The pneumococcal vaccine was developed to provide protection against infections caused by Streptococcus pneumoniae, or pneumococcus. It is available in two [...]

Published
2012

6. Outpatient treatment of pulmonary embolism safe for low-risk patients

Author

Garrett, Anna D.

Subjects
Drug therapy, Usage, Research, Pulmonary embolism -- Drug therapy -- Research, Practice guidelines (Medicine) -- Usage
Abstract

Despite practice guidelines recommending outpatient care for hemodynamically stable patients with pulmonary embolism (PE), most PE patients still receive hospital-based treatment. A recent international study suggests that outpatient care is [...]

Published
2011

8. AstraZeneca Pharmaceuticals LP

Subjects
AstraZeneca Pharmaceuticals L.P. -- Research, Exanta (Medication) -- Testing -- Evaluation, Pulmonary embolism -- Drug therapy -- Research, Pharmaceutical research -- Evaluation -- Research, Venous thrombosis -- Drug therapy -- Research, General interest, Health, Testing, Drug therapy, Evaluation, Research
Abstract

AstraZeneca Pharmaceuticals LP (Wilmington, DE) announced the results of a randomized, double-blind, Phase 3 study comparing Exanta (ximelagatran, formerly known as H376/95) with warfarin for the prevention of deep vein [...]

Published
2001

Catalog

Books, media, physical & digital resources
See catalog results